Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KABRIMED ApS
APS
Active
CVR 29189943
Trekanten 8
Precious metals production · NACE 2441
Est. 2005
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 21K
-73% vs 2023
EBITDA margin
40.0%
-89% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
DKK 6K
-90% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 21K
-73%
EBITDA
DKK 8K
-89%
Net profit
DKK 6K
-90%
Total assets
DKK 178K
-29%
Equity
DKK 168K
-25%
Employees
2
—
Company information
Legal name
KABRIMED ApS
CVR number
29189943
Legal form
Anpartsselskab
NACE code
2441 · Precious metals production
Founded
17. november 2005
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet ledes af en direktion, bestående af et eller flere medlemmer og fastsætter vilkårene for denne eller disses stilling.
Company purpose
Selskabets formål er at drive køb, salg, produktion og produktudvikling,.
Contact
Address
Trekanten 8
Phone
+4528959145
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Precious metals production
Companies in Aalborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
84
31
49
79
21
Staff expenses
-0
-0
-0
-0
-0
EBITDA
84
31
49
79
8
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
84
31
49
79
8
Net financials
-1
-2
-1
-0
-0
Profit before tax
82
29
47
79
8
Tax
18
6
10
17
2
Net profit
64
23
37
61
6
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
267
163
204
252
178
Equity
191
148
185
223
168
Long-term debt
0
0
0
0
0
Short-term debt
76
15
19
29
9
Total debt
76
15
19
29
9
Financial ratios
5-year trend
EBITDA margin
40.0%
This company
15.8%
Market median
+153% vs market
2020
2024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
2020
2024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
2020
2024
Net profit margin
30.2%
This company
8.1%
Market median
+273% vs market
2020
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Karl Brian Nielsen
Individual
100%
100%
2005
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of KABRIMED ApS also hold positions in
0
other companies.
Person
Role here
Other companies